Article Contents ::
- 1 The Brand Name FINABALD Has Generic Salt :: DUTASTERIDE
- 2 FINABALD Is From Company EAST WEST Priced :: Rs. 37.4
- 3 FINABALD have DUTASTERIDE is comes under Sub class Drugs For Prostate Disorders of Main Class Genito Urinary System
- 4 Main Medicine Class:: Genito Urinary System Sub Medicine Class :: Drugs For Prostate Disorders
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name FINABALD Has Generic Salt :: DUTASTERIDE
FINABALD Is From Company EAST WEST Priced :: Rs. 37.4
FINABALD have DUTASTERIDE is comes under Sub class Drugs For Prostate Disorders of Main Class Genito Urinary System
Main Medicine Class:: Genito Urinary System Sub Medicine Class :: Drugs For Prostate Disorders
|Salt Name : OR Generic Name||Form||Price : MRP /Probable||Packing|
Indications for Drugs ::
Benign prostatic hyperplasia (BPH)
Drug Dose ::
Adult: PO 500 mcg/day.
Severe liver impairment; pregnant women, children, adolescent.
Drug Precautions ::
Excreted in semen therefore use of condom is recommended. Women of childbearing potential should avoid handling dutasteride capsules. Advisable to exclude other causes of benign prostatic hypertrophy (e.g. prostate cancer, infection) before initiating therapy.
Drug Side Effects ::
Impotence; decreased libido; ejaculation disorders; breast tenderness and enlargement.
Pregnancy category ::
Drug Mode of Action ::
Dutasteride has antiandrogenic properties. It inhibits 5?-reductase, thus preventing the conversion of testosterone to 5?-dihydrotestosterone which is the main androgen involved in causing prostate enlargement.
Drug Interactions ::
Plasma concentrations may be increased when used concomitantly w/ moderate or potent CYP3A4 inhibitors.
Be the first to leave a review.